Journal Watch

Posted on by

Journal Watch
Vaccines and Global Health: The Week in Review continues its weekly scanning of key peer-reviewed journals to identify and cite articles, commentary and editorials, books reviews and other content supporting our focu-s on vaccine ethics and policy. Journal Watch is not intended to be exhaustive, but indicative of themes and issues the Center is actively tracking. We selectively provide full text of some editorial and comment articles that are specifically relevant to our work. Successful access to some of the links provided may require subscription or other access arrangement unique to the publisher.
If you would like to suggest other journal titles to include in this service, please contact David Curry at: david.r.curry@centerforvaccineethicsandpolicy.org

Ending the HIV Epidemic

Posted on by

AMA Journal of Ethics
Volume 23, Number 5: E371-433 May 2021
https://journalofethics.ama-assn.org/issue/ending-hiv-epidemic

 

Ending the HIV Epidemic
A human immunodeficiency virus (HIV) epidemic began in the United States in the 1970s. “Ending the HIV Epidemic: A Plan for America” was launched in October 2019 by the US Department of Health and Human Services, with the goal of stopping the spread of HIV by 2030. Accomplishing this goal demands not only expanding existing programs, but recognizing and responding to clinically, ethically, socially, and culturally relevant features of contemporary patients’ experiences of stigma, oppression, and living with HIV. This issue considers ethical and clinical complexities patients and clinicians encounter in HIV care today.

Modes of transmission of SARS-CoV-2 and evidence for preventive behavioral interventions

Posted on by

BMC Infectious Diseases
http://www.biomedcentral.com/bmcinfectdis/content
(Accessed 29 May 2021)

 

Modes of transmission of SARS-CoV-2 and evidence for preventive behavioral interventions
COVID-19 is a novel disease caused by SARS-CoV-2. During the global vaccination rollout, it is vital to thoroughly understand the modes of transmission of the virus in order to prevent further spread of varian…
Authors: Lucas Zhou, Samuel K. Ayeh, Vignesh Chidambaram and Petros C. Karakousis
Citation: BMC Infectious Diseases 2021 21:496
Content type: Review
Published on: 28 May 2021

Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis

Posted on by

BMC Infectious Diseases
http://www.biomedcentral.com/bmcinfectdis/content
(Accessed 29 May 2021)

 

Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis
Favipiravir possesses high utility for treating patients with COVID-19. However, research examining the efficacy and safety of favipiravir for patients with COVID-19 is limited.
Authors: Toshie Manabe, Dan Kambayashi, Hiroyasu Akatsu and Koichiro Kudo
Citation: BMC Infectious Diseases 2021 21:489
Content type: Research article
Published on: 27 May 2021

Stakeholders’ perspectives on research integrity training practices: a qualitative study

Posted on by

BMC Medical Ethics
http://www.biomedcentral.com/bmcmedethics/content
(Accessed 29 May 2021)

 

Stakeholders’ perspectives on research integrity training practices: a qualitative study
Even though research integrity (RI) training programs have been developed in the last decades, it is argued that current training practices are not always able to increase RI-related awareness within the scien…
Authors: Daniel Pizzolato and Kris Dierickx
Citation: BMC Medical Ethics 2021 22:67
Content type: Research article
Published on: 28 May 2021

Intention to receive a COVID-19 vaccine: results from a population-based survey in Canada

Posted on by

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 29 May 2021)

 

Intention to receive a COVID-19 vaccine: results from a population-based survey in Canada
The success of any COVID-19 vaccine program ultimately depends on high vaccine uptake. This study determined overall intention to receive a COVID-19 vaccine and identified factors that predict intentions to be…
Authors: Gina S. Ogilvie, Shanlea Gordon, Laurie W. Smith, Arianne Albert, C. Sarai Racey, Amy Booth, Anna Gottschlich, David Goldfarb, Melanie C. M. Murray, Liisa A. M. Galea, Angela Kaida, Lori A. Brotto and Manish Sadarangani
Citation: BMC Public Health 2021 21:1017
Content type: Research
Published on: 29 May 2021

Attitudes of Lebanese adults regarding COVID-19 vaccination

Posted on by

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 29 May 2021)

 

Attitudes of Lebanese adults regarding COVID-19 vaccination
COVID-19 was first detected in Lebanon on February 21, 2020; it reached its peak in January 2021, with a total number of 418,448 confirmed cases and 5380 deaths (until March 15, 2021). Gaining insight into fac…
Authors: Carina Kasrine Al Halabi, Sahar Obeid, Hala Sacre, Marwan Akel, Rabih Hallit, Pascale Salameh and Souheil Hallit
Citation: BMC Public Health 2021 21:998
Content type: Research
Published on: 27 May 2021

SARS-CoV-2 Human Challenge Trials: Rethinking the Recruitment of Healthy Young Adults First

Posted on by

Ethics & Human Research
Volume 43, Issue 3 Pages: 1-44 May–June 2021
https://onlinelibrary.wiley.com/toc/25782363/current

 

Underrepresented populations in clinical research Human infection challenge trials
Articles
SARS-CoV-2 Human Challenge Trials: Rethinking the Recruitment of Healthy Young Adults First
Kenji Matsui, Yusuke Inoue, Keiichiro Yamamoto
Pages: 37-41
First Published: 06 April 2021

Underrepresented populations in clinical research Human infection challenge trials

Posted on by

Ethics & Human Research
Volume 43, Issue 3 Pages: 1-44 May–June 2021
https://onlinelibrary.wiley.com/toc/25782363/current

 

Underrepresented populations in clinical research Human infection challenge trials
Articles
SARS-CoV-2 Human Challenge Trials: Rethinking the Recruitment of Healthy Young Adults First
Kenji Matsui, Yusuke Inoue, Keiichiro Yamamoto
Pages: 37-41
First Published: 06 April 2021

Demonstrating trustworthiness when collecting and sharing genomic data: public views across 22 countries

Posted on by

Genome Medicine
https://genomemedicine.biomedcentral.com/articles
[Accessed 29 May 2021]

 

Demonstrating trustworthiness when collecting and sharing genomic data: public views across 22 countries
Public trust is central to the collection of genomic and health data and the sustainability of genomic research. To merit trust, those involved in collecting and sharing data need to demonstrate they are trustworthy. However, it is unclear what measures are most likely to demonstrate this.
We analyse the ‘Your DNA, Your Say’ online survey of public perspectives on genomic data sharing including responses from 36,268 individuals across 22 low-, middle- and high-income countries, gathered in 15 languages. We examine how participants perceived the relative value of measures to demonstrate the trustworthiness of those using donated DNA and/or medical information. We examine between-country variation and present a consolidated ranking of measures.
Authors: Richard Milne, Katherine I. Morley, Mohamed A. Almarri, Shamim Anwer, Jerome Atutornu, Elena E. Baranova, Paul Bevan, Maria Cerezo, Yali Cong, Alessia Costa, Christine Critchley, Josepine Fernow, Peter Goodhand, Qurratulain Hasan, Aiko Hibino, Gry Houeland…
Citation: Genome Medicine 2021 13:92
Content type: Research
Published on: 25 May 2021

Socio-economic determinants of global COVID-19 mortalities: policy lessons for current and future pandemics

Posted on by

Health Policy and Planning
Volume 36, Issue 4, May 2021
https://academic.oup.com/heapol/issue/36/4

 

ORIGINAL ARTICLES
Socio-economic determinants of global COVID-19 mortalities: policy lessons for current and future pandemics
Nicholas Ngepah
Health Policy and Planning, Volume 36, Issue 4, May 2021, Pages 418–434, https://doi.org/10.1093/heapol/czaa161

Impact of campaign-style delivery of routine vaccines: a quasi-experimental evaluation using routine health services data in India

Posted on by

Health Policy and Planning
Volume 36, Issue 4, May 2021
https://academic.oup.com/heapol/issue/36/4

Impact of campaign-style delivery of routine vaccines: a quasi-experimental evaluation using routine health services data in India
Emma Clarke-Deelder, Christian Suharlim, Susmita Chatterjee, Logan Brenzel, Arindam Ray …

 

Health Policy and Planning, Volume 36, Issue 4, May 2021, Pages 454–463, https://doi.org/10.1093/heapol/czab026

Localisation and local humanitarian action

Posted on by

Humanitarian Exchange Magazine
Number 79, May 2021
https://odihpn.org/magazine/inclusion-of-persons-with-disabilities-in-humanitarian-action-what-now/

 

Localisation and local humanitarian action
by HPN October 2020
The theme of this edition of Humanitarian Exchange is localisation+ and local humanitarian action. Five years ago this week, donors, United Nations (UN) agencies,  non-governmental organisations (NGOs), the International Committee of the Red Cross (ICRC) and International Federation of Red Cross and Red Crescent Societies (IFRC) committed within the Grand Bargain to increase multi-year investments in the institutional capacities of local and national responders, and to provide at least 25% of humanitarian funding to them as directly as possible. Since then, there is increasing consensus at policy and normative level, underscored by the Covid-19 pandemic, that local leadership should be supported.  Localisation has gone from a fringe conversation among policy-makers and aid agencies in 2016 to a formal priority under the Grand Bargain. Wider global movements on anti-racism and decolonisation have also brought new momentum to critical reflections on where power, knowledge and capacity reside in the humanitarian system. Yet progress has been slow and major gaps remain between the rhetoric around humanitarian partnerships, funding and coordination and practices on the ground.

Overview of the Issue

Posted on by

Journal of Health Care for the Poor and Underserved (JHCPU)
Volume 32, Number 2, May 2021 Supplement
https://muse.jhu.edu/issue/44396

 

Table of Contents
Overview of the Issue
Kevin B. Johnson, Tiffani J. Bright, Cheryl R. Clark
…The importance of techquity—defined as the strategic development and deployment of technology in health care and health to advance health equity—was even more apparent after the events of 2020. COVID-19 upended access to care and illuminated the impact of structural racism as a cause for a widening gap of access during the pandemic. Black Lives Matter became more than a trending hashtag on Twitter, or a movement resulting in peaceful protests and calls for policy reform: it put additional focus on the issue of race as a social and not a biological construct and called into question the rationale for common practices in health care that were triggered by race. A notable example was the emerging realization that kidney function assessment was tied to race and hardwired into many of our electronic health records. The real-world evidence around our lack of techquity was incontrovertible.
This Supplemental Issue of JHCPU provides articles that describe challenges to techquity, frameworks to improve the role of technology in care, and examples of how technology can transform health, public health, and health care…

The “Legal Epidemiology” of Pandemic Control

Posted on by

New England Journal of Medicine
May 27, 2021 Vol. 384 No. 21
http://www.nejm.org/toc/nejm/medical-journal

 

Perspective
The “Legal Epidemiology” of Pandemic Control
Scott Burris, J.D., Evan D. Anderson, J.D., Ph.D., and Alexander C. Wagenaar, M.S.W., Ph.D.
The centrality of law as a public health intervention has been undeniable during the Covid-19 pandemic. In just the first half of 2020, more than 1000 laws and orders were issued by federal, state, and local authorities in the United States in an effort to reduce disease transmission. Legal interventions include stay-at-home orders, mask mandates, and travel restrictions, as well as more particular rules for business operations, alcohol sales, curfews, and health care. Given their heavy use, importance, and obvious socioeconomic side effects, and the social and behavioral complexities of their implementation, one might have expected the National Institutes of Health (NIH), other research funders, and the research community to jump to the work of determining the right mix, intensity, and enforcement approaches of legal restrictions to control transmission with the least and most equitably distributed harms. No organized research program emerged…

A Hidden Opportunity — Medicaid’s Role in Supporting Equitable Access to Clinical Trials

Posted on by

New England Journal of Medicine
May 27, 2021 Vol. 384 No. 21
http://www.nejm.org/toc/nejm/medical-journal

 

Perspective
A Hidden Opportunity — Medicaid’s Role in Supporting Equitable Access to Clinical Trials
Samuel U. Takvorian, M.D., M.S.H.P., Carmen E. Guerra, M.D., M.S.C.E., and William L. Schpero, Ph.D.
Hidden deep within the $2.3 trillion omnibus spending and relief package passed by Congress in December 2020 lies a little-known but powerful provision intended to promote equitable access to clinical trials. Beginning in January 2022, coverage of the “routine costs” associated with clinical trial participation will be guaranteed for all Medicaid beneficiaries for the first time in the program’s history. The absence of federal policy in this area until now has most likely suppressed the representation of low-income and minority populations in the clinical research that underlies therapeutic advances, thereby limiting equitable access to potentially state-of-the-art therapies and compromising the generalizability of research findings…

The impact of the COVID-19 pandemic on rabies reemergence in Latin America: The case of Arequipa, Peru

Posted on by

PLoS Neglected Tropical Diseases
http://www.plosntds.org/
(Accessed 29 May 2021)

 

The impact of the COVID-19 pandemic on rabies reemergence in Latin America: The case of Arequipa, Peru
Brinkley Raynor, Elvis W. Díaz, Julianna Shinnick, Edith Zegarra, Ynes Monroy, Claudia Mena, Micaela De la Puente-León, Michael Z. Levy, Ricardo Castillo-Neyra
Research Article | published 21 May 2021 PLOS Neglected Tropical Diseases
https://doi.org/10.1371/journal.pntd.0009414

Impact of influenza vaccination in the Netherlands, 2007–2016: Vaccinees consult their general practitioner for clinically diagnosed influenza, acute respiratory infections, and pneumonia more often than non-vaccinees

Posted on by

PLoS One
http://www.plosone.org/
[Accessed 29 May 2021]

 

Impact of influenza vaccination in the Netherlands, 2007–2016: Vaccinees consult their general practitioner for clinically diagnosed influenza, acute respiratory infections, and pneumonia more often than non-vaccinees
Saverio Caini, John Paget, Peter Spreeuwenberg, Joke C. Korevaar, Adam Meijer, Mariëtte Hooiveld
Research Article | published 28 May 2021 PLOS ONE
https://doi.org/10.1371/journal.pone.0249883

Willingness to participate in COVID-19 vaccine trials; a survey among a population of healthcare workers in Uganda

Posted on by

PLoS One
http://www.plosone.org/
[Accessed 29 May 2021]

 

Willingness to participate in COVID-19 vaccine trials; a survey among a population of healthcare workers in Uganda
Jonathan Kitonsa, Onesmus Kamacooko, Ubaldo Mushabe Bahemuka, Freddie Kibengo, Ayoub Kakande, Anne Wajja, Vincent Basajja, Alfred Lumala, Edward Ssemwanga, Robert Asaba, Joseph Mugisha, Benjamin F. Pierce, Robin Shattock, Pontiano Kaleebu, Eugene Ruzagira
Research Article | published 27 May 2021 PLOS ONE
https://doi.org/10.1371/journal.pone.0251992

Booster immunization of meningococcal meningitis vaccine among children in Hangzhou, China, 2014-2019

Posted on by

PLoS One
http://www.plosone.org/
[Accessed 29 May 2021]

 

Booster immunization of meningococcal meningitis vaccine among children in Hangzhou, China, 2014-2019
Xinren Che, Yan Liu, Jun Wang, Yuyang Xu, Xuechao Zhang, Wenwen Gu, Wei Jiang, Jian Du, Xiaoping Zhang
Research Article | published 25 May 2021 PLOS ONE
https://doi.org/10.1371/journal.pone.0251567

Factors indicating intention to vaccinate with a COVID-19 vaccine among older U.S. adults

Posted on by

PLoS One
http://www.plosone.org/
[Accessed 29 May 2021]

 

Factors indicating intention to vaccinate with a COVID-19 vaccine among older U.S. adults
Janeta Nikolovski, Martin Koldijk, Gerrit Jan Weverling, John Spertus, Mintu Turakhia, Leslie Saxon, Mike Gibson, John Whang, Troy Sarich, Robert Zambon, Nnamdi Ezeanochie, Jennifer Turgiss, Robyn Jones, Jeff Stoddard, Paul Burton, Ann Marie Navar
Research Article | published 24 May 2021 PLOS ONE
https://doi.org/10.1371/journal.pone.0251963

A megastudy of text-based nudges encouraging patients to get vaccinated at an upcoming doctor’s appointment

Posted on by

PNAS – Proceedings of the National Academy of Sciences of the United States of America
May 11, 2021; vol. 118 no. 19
https://www.pnas.org/content/118/19

 

Brief Reports Open Access
A megastudy of text-based nudges encouraging patients to get vaccinated at an upcoming doctor’s appointment
Katherine L. Milkman, Mitesh S. Patel, Linnea Gandhi, Heather N. Graci, Dena M. Gromet, Hung Ho, Joseph S. Kay, Timothy W. Lee, Modupe Akinola, John Beshears, Jonathan E. Bogard, Alison Buttenheim, Christopher F. Chabris, Gretchen B. Chapman, James J. Choi, Hengchen Dai, Craig R. Fox, Amir Goren, Matthew D. Hilchey, Jillian Hmurovic, Leslie K. John, Dean Karlan, Melanie Kim, David Laibson, Cait Lamberton, Brigitte C. Madrian, Michelle N. Meyer, Maria Modanu, Jimin Nam, Todd Rogers, Renante Rondina, Silvia Saccardo, Maheen Shermohammed, Dilip Soman, Jehan Sparks, Caleb Warren, Megan Weber, Ron Berman, Chalanda N. Evans, Christopher K. Snider, Eli Tsukayama, Christophe Van den Bulte, Kevin G. Volpp, and Angela L. Duckworth
PNAS May 18, 2021 118 (20) e2101165118; https://doi.org/10.1073/pnas.2101165118

Socioeconomic inequalities in HIV knowledge, HIV testing, and condom use among adolescent and young women in Latin America and the Caribbean

Posted on by

Revista Panamericana de Salud Pública/Pan American Journal of Public Health (RPSP/PAJPH)
https://www.paho.org/journal/en

 

25 May 2021
Socioeconomic inequalities in HIV knowledge, HIV testing, and condom use among adolescent and young women in Latin America and the Caribbean
Original research | English |

Resurgence of SARS-CoV-2: Detection by community viral surveillance

Posted on by

Science
28 May 2021 Vol 372, Issue 6545
http://www.sciencemag.org/current.dtl

 

 

Reports
Resurgence of SARS-CoV-2: Detection by community viral surveillance
By Steven Riley, Kylie E. C. Ainslie, Oliver Eales, Caroline E. Walters, Haowei Wang, Christina Atchison, Claudio Fronterre, Peter J. Diggle, Deborah Ashby, Christl A. Donnelly, Graham Cooke, Wendy Barclay, Helen Ward, Ara Darzi, Paul Elliott
Science28 May 2021 : 990-995 Open Access
Representative community antigen sampling can improve situational awareness and help evaluate interventions at low SARS-CoV-2 prevalence.

Evidence on collaboration of traditional and biomedical practitioners in the management of antimicrobial resistance in sub-Saharan Africa over 15 years: a systematic review protocol

Posted on by

Systematic Reviews
https://systematicreviewsjournal.biomedcentral.com/articles
[Accessed 29 May 2021]

 

Evidence on collaboration of traditional and biomedical practitioners in the management of antimicrobial resistance in sub-Saharan Africa over 15 years: a systematic review protocol
The overuse of prescribed antimicrobials, concurrent use of traditional medicine, and prescribed antimicrobials have led to antimicrobial resistance. The absence of collaboration between traditional health pra…
Authors: Aganze Gloire-Aimé Mushebenge, Mukanda Gedeon Kadima, Tivani Mashamba-Thompson and Manimbulu Nlooto
Citation: Systematic Reviews 2021 10:158
Content type: Protocol
Published on: 28 May 2021

Ethics and execution of developing a 2nd wave COVID vaccine – Our interim phase I/II VSV-SARS-CoV2 vaccine experience

Posted on by

Vaccine
Volume 39, Issue 21 Pages 2811-2906 (18 May 2021)
https://www.sciencedirect.com/journal/vaccine/vol/39/issue/21

 

Discussion Full text access
Ethics and execution of developing a 2nd wave COVID vaccine – Our interim phase I/II VSV-SARS-CoV2 vaccine experience
Yotam Levin, Noa Madar Balakirski, Yoseph Caraco, Eytan Ben-Ami, … Hadar Marcus
Pages 2821-2823

Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: A national cross-sectional study

Posted on by

Vaccine
Volume 39, Issue 21 Pages 2811-2906 (18 May 2021)
https://www.sciencedirect.com/journal/vaccine/vol/39/issue/21

 

Research article Full text access
Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: A national cross-sectional study
Chao Wang, Bingfeng Han, Tianshuo Zhao, Hanyu Liu, … Fuqiang Cui
Pages 2833-2842

Incorporating equity in infectious disease modeling: Case study of a distributional impact framework for measles transmission

Posted on by

Vaccine
Volume 39, Issue 21 Pages 2811-2906 (18 May 2021)
https://www.sciencedirect.com/journal/vaccine/vol/39/issue/21

 

Research article Open access
Incorporating equity in infectious disease modeling: Case study of a distributional impact framework for measles transmission
Tigist Ferede Menkir, Abdulrahman Jbaily, Stéphane Verguet
Pages 2894-2900

Vaccine Production Process: How Much Does the General Population Know about This Topic? A Web-Based Survey

Posted on by

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines

 

(Accessed 29 May 2021)
Open Access Article
Vaccine Production Process: How Much Does the General Population Know about This Topic? A Web-Based Survey
by Angela Bechini et al
Vaccines 2021, 9(6), 564; https://doi.org/10.3390/vaccines9060564 (registering DOI) – 29 May 2021
Abstract
Background: Vaccine hesitancy has been recognized as a major global health threat by the World Health Organization. Many studies have investigated vaccine safety as a determinant for vaccine hesitancy; however, not much attention has been paid to vaccine production and quality control during […]

Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects

Posted on by

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines

 

Open Access Article
Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects
by Ma’mon M. Hatmal et al
Vaccines 2021, 9(6), 556; https://doi.org/10.3390/vaccines9060556 – 26 May 2021
Abstract
Background: Since the coronavirus disease 2019 (COVID-19) was declared a pandemic, there was no doubt that vaccination is the ideal protocol to tackle it. Within a year, a few COVID-19 vaccines have been developed and authorized. This unparalleled initiative in developing vaccines created […]

Maternal Vaccination in Uganda: Exploring Pregnant Women, Community Leaders and Healthcare Workers’ Perceptions

Posted on by

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines

 

Open Access Article
Maternal Vaccination in Uganda: Exploring Pregnant Women, Community Leaders and Healthcare Workers’ Perceptions
By Phiona Nalubega
Vaccines 2021, 9(6), 552; https://doi.org/10.3390/vaccines9060552 – 25 May 2021
Abstract
Background: We investigated pregnant women, community leaders, healthcare workers (HCWs) and programme managers’ perceptions of maternal vaccination in Kampala, Uganda. Methods: We conducted focus group discussions, key informant interviews and in-depth discussions with HCWs (3), community leaders (3), pregnant women (8) and programme […]

Factors Influencing Public Attitudes towards COVID-19 Vaccination: A Scoping Review Informed by the Socio-Ecological Model

Posted on by

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines

 

Open Access Review
Factors Influencing Public Attitudes towards COVID-19 Vaccination: A Scoping Review Informed by the Socio-Ecological Model
by Ghadir Fakhri Al-Jayyousi
Vaccines 2021, 9(6), 548; https://doi.org/10.3390/vaccines9060548 – 24 May 2021
Abstract
Major hindrances to getting a COVID-19 vaccine include vaccine hesitancy, skepticism, refusal, and anti-vaccine movements. Several studies have been conducted on attitudes of the public towards COVID-19 vaccines and the potential influencing factors. The purpose of this scoping review is to summarize the […

Media/Policy Watch

Posted on by

Media/Policy Watch
This watch section is intended to alert readers to substantive news, analysis and opinion from the general media and selected think tanks and similar organizations on vaccines, immunization, global public health and related themes. Media Watch is not intended to be exhaustive, but indicative of themes and issues CVEP is actively tracking. This section will grow from an initial base of newspapers, magazines and blog sources, and is segregated from Journal Watch above which scans the peer-reviewed journal ecology.
We acknowledge the Western/Northern bias in this initial selection of titles and invite suggestions for expanded coverage. We are conservative in our outlook in adding news sources which largely report on primary content we are already covering above. Many electronic media sources have tiered, fee-based subscription models for access. We will provide full-text where content is published without restriction, but most publications require registration and some subscription level.
The sheer volume of vaccine and pandemic-related coverage is extraordinary. We will strive to present the most substantive analysis and commentary we encounter.

 

The Atlantic
http://www.theatlantic.com/magazine/
Accessed 29 May 2021
[No new, unique, relevant content]

 

BBC
http://www.bbc.co.uk/
Accessed 29 May 2021
[No new, unique, relevant content]

 

The Economist
http://www.economist.com/
Accessed 29 May 2021
Possible, but far from proven – Assessing the theory that covid-19 leaked from a Chinese lab
The evidence so far is circumstantial
May 29th 2021 edition

 

Financial Times
https://www.ft.com/
Accessed 29 May 2021
Malaysia announces ‘total lockdown’ after surge in cases and deaths
May 28, 2021

Covid-19 vaccines
WHO reboots IP sharing scheme for Covid shots, drugs and tests
May 27, 2021
Top of Form
Bottom of Form

 

Forbes
http://www.forbes.com/
Accessed 29 May 2021
May 29, 2021
Some Countries With The Highest Vaccination Rates Are Facing A Surge In Covid Deaths And Infections–Experts Say Complacency Is Partly To Blame
Countries with much higher vaccination rates than the U.S. are experiencing deadly outbreaks of Covid-19.
By Robert Hart Forbes Staff

May 28, 2021
Employers Can Require Workers To Get Vaccinated, Government Says
The Equal Employment Opportunity Commission also said employers can offer vaccine incentives to their workers, such as cash stipends.
By Jack Brewster Forbes Staff

 

Foreign Affairs
http://www.foreignaffairs.com/
Accessed 29 May 2021
Snapshot May 26, 2021
India’s Cascading COVID-19 Failures
The staggering cost of an unscientific response to the pandemic.
Ramanan Laxminarayan

 

Foreign Policy
http://foreignpolicy.com/
Accessed 29 May 2021
Latin America’s Vaccine Stars and Struggles
Technology transfers to produce shots are slowly underway in the region.
By Catherine Osborn May 21, 2021

 

New Yorker
http://www.newyorker.com/
Accessed 29 May 2021
Annals of Inquiry
The Sudden Rise of the Coronavirus Lab-Leak Theory
Scientists and political commentators are no longer dismissing the possibility that COVID-19 emerged from a Chinese laboratory. What changed?
By Benjamin Wallace-Wells
May 27, 2021

 

New York Times
http://www.nytimes.com/
Accessed 29 May 2021
Europe
Hundreds Protest Vaccine Passports in London
Demonstrators opposing coronavirus vaccines and the idea of vaccine passports gathered in central London on Saturday.
By The Associated Press and Reuters
May 29, 2021

Americas
‘Like a Dream’: Latin Americans Head to U.S. for Covid Shots
Frustrated with the lagging pace of vaccinations at home, well-off Latin Americans have been flying north for a shot — and feeling guilty about those left behind.
By Ernesto Londoño, Daniel Politi and Santi Carneri
May 29, 2021

U.S.
California to Give $116.5 million to Vaccinated Residents
Gov. Gavin Newsom of California announced on Thursday a $116.5 million giveaway to residents who have received a coronavirus vaccination in an effort to motivate people to get a shot.

Asia Pacific
Japan extends a state of emergency until one month before the Olympics.
With infections still high, restrictions in nine prefectures will remain in place until at least June 20, casting more doubt on the start of the Summer Games in Tokyo.
By Hisako Ueno and Motoko Rich
May 28, 2021

Opinion
Vaccinate the World! The Best Investment Ever.
Here’s a way for Biden to assert United States leadership to benefit the world and safeguard the American economy.
By Nicholas Kristof
PRINT EDITION May 27, 2021, Page A18

Business
Influencers Say They Were Urged to Criticize Pfizer Vaccine
A disinformation effort to reduce public confidence in Covid-19 vaccines tried to enroll social media commentators in France and Germany.
By Liz Alderman

Opinion Guest Essay
This Is the Wrong Way to Distribute Badly Needed Vaccines
May 24, 2021
By Ezekiel J. Emanuel and Govind Persad
…But to be fair and successful, Covax must abandon its purely population-based distribution formula, developed by W.H.O., which has led to precious vaccine doses being destroyed or left sitting in freezers in countries without many cases or which lack the ability to distribute them effectively. Fair distribution of vaccines must be based primarily on need…
…Need should be the principal criterion for distributing vaccines among countries, but not the only one. Before vaccines are sent, countries must be able to distribute and administer them. Vaccinations — not vaccines — are what save lives. Support must be provided to countries like South Sudan, Malawi and Ivory Coast to upgrade their capacity to distribute vaccines…
..As the global supply of vaccines expands, vaccine manufacturers and nations expecting to have extra doses, including the United States and Britain, must decide which countries to help and how many doses to send to global organizations like Covax.
But if Covax’s distribution criteria remain unresponsive to need, countries with spare doses should bypass the organization and distribute them where they will reduce deaths the most. It would be morally indefensible to give vaccines to Covax to send to countries with few cases or that are unable to deliver vaccines, while outbreaks rage elsewhere…

How to Allocate Vaccines Fairly: Covax’s View
May 27, 2021 Letter to the Editor:
Re “The Wrong Way to Distribute Vaccines,” by Ezekiel J. Emanuel and Govind Persad (Opinion guest essay, May 25):
The suggestion that it is unethical to allocate vaccines equitably across all nations when some countries are faring worse against the ravages of Covid-19 than others misses one crucial fact: Vaccines are at their most effective when preventing surges of the virus, not combating them once they have taken hold.
When outbreaks occur, the critical tools available to governments are of the nonpharmaceutical variety, such as lockdowns, distancing and mask wearing. Vaccines are also a part of the solution, but with up to three months needed for a two-dose Oxford/AstraZeneca vaccination, followed by a two-week wait in order to achieve full protection, they are not an acute intervention even if there are enough to go around.
We don’t know where the next surge will hit or when the next variant will emerge, which is why Covax’s goal to protect the most vulnerable everywhere is, at this stage of the pandemic, the right thing to do. This not only means maximizing the chances of survival for the health workers, elderly and vulnerable whose lives are most at risk, but also minimizing the chances that new, more dangerous variants will come along.
The real issue with vaccines today is not how to divvy up a small slice of the pie for less wealthy nations but how to make their slice bigger, which is why governments and manufacturers of vaccines must do everything in their power to get as many doses as possible to Covax now.
Seth Berkley
Soumya Swaminathan
Richard Hatchett
Dr. Berkley is chief executive of Gavi, the Vaccine Alliance. Dr. Swaminathan is chief scientist of the World Health Organization. Dr. Hatchett is chief executive of the Coalition for Epidemic Preparedness Innovations. Their organizations co-lead Covax.

 

Washington Post
https://www.washingtonpost.com/
Accessed 29 May 2021
[No new, unique, relevant content]

Think Tanks et al

Posted on by

Think Tanks et al
 
 
Brookings
http://www.brookings.edu/
Accessed 29 May 2021
Future Development
COVID-19 is a developing country pandemic
Indermit Gill and Philip Schellekens
Thursday, May 27, 2021
 
 
Center for Global Development [to 29 May 2021]
http://www.cgdev.org/page/press-center
Event
Developing a Plan to Vaccinate the World
6/2/21
While vaccine R&D stands out as a success in the ongoing response to COVID-19, there is still a long way to go to meet vaccination needs, particularly in low- and middle-income countries

To Increase Vaccine Manufacturing in LMICs, We Also Need to Strengthen Regulatory Capacity
May 25, 2021
A lot of recent discussions focus on how to expand COVID-19 vaccine manufacturing capacity in low- and middle-income countries (LMICs). The conversations highlight the importance of technology transfer and the capability of the tech transfer receiving sites (the facilities in these countries that would then produce vaccines locally), including having specialized equipment and personnel.
Javier Guzman and Prashant Yadav
 
 
Chatham House [to 29 May 2021]
https://www.chathamhouse.org/
Accessed 29 May 2021
[No new digest content]

 
 
CSIS
https://www.csis.org/
Accessed 29 May 2021
[No new digest content]

 
 

Kaiser Family Foundation
https://www.kff.org/search/?post_type=press-release
Accessed 29 May 2021
May 28, 2021 News Release
Vaccine Monitor: Vaccination Rates Continue to Inch Upwards Across Groups, Especially Amo ng Hispanic Adults, But Few Who Are Eager to Get a Shot Remain Unvaccinated
4 in 10 Parents Say Their Adolescent Children Have Already Gotten a Shot or Will Do So Right Away; One Quarter of Parents of Children Under 12 Will Get Them Vaccinated as Soon as They Are Eligible Few Unvaccinated Adults Say that CDC’s Guidelines for Vaccinated Adults Make Them More…

May 26, 2021 News Release
The Pandemic’s Impact on Children’s Mental Health
The pandemic has taken a heavy toll on the nation’s mental health, and a new issue brief shows that children are also facing worsening emotional and cognitive health. The brief examines factors contributing to worsening mental health and substance use outcomes among children and adolescents during the pandemic, looking closely…

Vaccines and Global Health: The Week in Review :: 22 May 2021

Posted on by

Vaccines and Global Health: The Week in Review is a weekly digest  summarizing news, events, announcements, peer-reviewed articles and research in the global vaccine ethics and policy space. Content is aggregated from key governmental, NGO, international organization and industry sources, key peer-reviewed journals, and other media channels. This summary proceeds from the broad base of themes and issues monitored by the Center for Vaccine Ethics & Policy in its work: it is not intended to be exhaustive in its coverage. You are viewing the blog version of our weekly digest, typically comprised of between 30 and 40 posts below all dated with the current issue date

.– Request an Email Summary: Vaccines and Global Health : The Week in Review is published as a single email summary, scheduled for release each Saturday evening before midnight (EDT in the U.S.). If you would like to receive the email version, please send your request to david.r.curry@centerforvaccineethicsandpolicy.org.

– pdf version:  A pdf of the current issue is available here: 

vaccines-and-global-health_the-week-in-review_22-may-2021Download

– blog edition: comprised of the approx. 35+ entries posted below.

– Twitter:  Readers can also follow developments on twitter: @vaxethicspolicy.
.
– Links:  We endeavor to test each link as we incorporate it into any post, but recognize that some links may become “stale” as publications and websites reorganize content over time. We apologize in advance for any links that may not be operative. We believe the contextual information in a given post should allow retrieval, but please contact us as above for assistance if necessary.

Support this knowledge-sharing service: Your financial support helps us cover our costs and to address a current shortfall in our annual operating budget. Click here to donate and thank you in advance for your contribution.

.
David R. Curry, MS
Executive Director
Center for Vaccine Ethics and Policy

World Health Assembly

Posted on by

Milestones :: Perspectives :: Research

 

World Health Assembly

Seventy-fourth World Health Assembly #WHA74
24 May to 1 June 2021
Theme: Ending this pandemic, preventing the next: building together a healthier, safer and fairer world.
:: Provisional agenda
:: Watch live WHA74 sessions
:: Documents

World Health Assembly to focus on ending COVID-19 pandemic and preparing for next one
News release 19 May 2021
In a year when COVID-19 threatens the health and well-being of everyone on the planet, the seventy-fourth session of the World Health Assembly (WHA) will stress the urgency of ending the current pandemic and preventing the next one by building a healthier, safer and fairer world…
This year’s World Health Assembly will play a vital role in shaping the global health architecture of the future, and in strengthening WHO to fulfil its mission and mandate”, added Dr Tedros.
The Assembly’s agenda will focus on the health-related Sustainable Development Goals and WHO’s Triple Billion targets of one billion more people benefitting from universal health coverage; one billion more better protected from health emergencies; and one billion more enjoying better health and well-being…

Extraordinary meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) – 27 May 2021

Posted on by

Milestones :: Perspectives :: Research

 

Extraordinary meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) – 27 May 2021
27 May 2021
This extraordinary virtual meeting for the Strategic Advisory Group of Experts on Immunization (SAGE) will take place on Thursday 27 May 2021 to propose recommendations to WHO on the use of COVID-19 vaccine(s).
:: Agenda